Pacific Biosciences' Q3 Revenues Drop 73 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Pacific Biosciences reported after the close of the market Thursday that its third-quarter revenues dropped 73 percent year over year as the firm trimmed its net loss.

The Menlo Park, Calif.-based single-molecule sequencing technology firm reported total revenues of $2.8 million for the quarter ended Sept. 30, down from $10.5 million for Q3 2011. Analysts, on average, had expected revenues of $3.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.